PHYH and metabolic disease: To elucidate the mechanism by which phytosphingosine improves metabolic disorders, RNA-seq and analysis were performed on liver samples from five groups (the PBS1 vs. F. plautii groups; the PBS2 vs. PhyH, or PhyL groups) (Fig. 6a).